These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8447132)

  • 1. Optimization of isolated hyperthermic limb perfusion.
    Omlor G
    World J Surg; 1993; 17(1):134. PubMed ID: 8447132
    [No Abstract]   [Full Text] [Related]  

  • 2. [Isolated limb hyperthermic perfusion chemotherapy for melanoma of the extremities].
    Li J; Wang P; Zhu XJ; Song JG; Song JM
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):937-9. PubMed ID: 23336382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of isolated hyperthermic limb perfusion.
    Omlor G; Gross G; Ecker KW; Burger I; Feifel G
    World J Surg; 1992; 16(6):1117-9. PubMed ID: 1455882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, toxicity, and short-term results of cisplatin hyperthermic isolated limb perfusion for soft-tissue sarcoma and melanoma of the extremities.
    Pommier RF; Moseley HS; Cohen J; Huang CS; Townsend R; Fletcher WS
    Am J Surg; 1988 May; 155(5):667-71. PubMed ID: 3369621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional hyperthermic perfusion with cisplatin following surgery for malignant melanoma of the extremities.
    Papa MZ; Klein E; Karni T; Koller M; Davidson B; Azizi E; Ben-Ari G
    Am J Surg; 1996 Apr; 171(4):416-20. PubMed ID: 8604833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safe use of cisplatin in hyperthermic isolated limb perfusion systems.
    Roseman JM; Tench D; Bryant LR
    Cancer; 1985 Aug; 56(4):742-4. PubMed ID: 4040418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Soft tissue sarcoma: isolated hyperthermic extremity perfusion. Technique and indications].
    Schlag PM; Kettelhack C
    Chirurg; 1993 Jun; 64(6):455-60. PubMed ID: 8359057
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the method of hyperthermic chemotherapy by regional isolated perfusion for tumors of lower extremities].
    Xu SW; Chen F; Chao YH
    Zhonghua Zhong Liu Za Zhi; 1994 Jul; 16(4):310-3. PubMed ID: 7805565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated limb perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs.
    Thompson JF; Gianoutsos MP
    World J Surg; 1992; 16(2):227-33. PubMed ID: 1561803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of cisplatin hyperthermic isolation perfusion for stage IIIA and IIIAB extremity melanoma.
    Fletcher WS; Pommier R; Small K
    Melanoma Res; 1994 Mar; 4 Suppl 1():17-9. PubMed ID: 8038590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated regional limb hyperthermic perfusion as treatment for melanoma.
    Loescher LJ; Leigh S
    Cancer Nurs; 1984 Dec; 7(6):461-7. PubMed ID: 6568866
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intraperitoneal hyperthermic perfusion chemotherapy in recurrent ovarian cancer].
    Wydra D; Emerich J
    Ginekol Pol; 2002 Nov; 73(11):1044-7. PubMed ID: 12722397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthermic isolated limb perfusion with cis-diamminedichloro-platinum. II. An experimental study in dogs with a balloon-occlusion technique for repeated high-dose treatment.
    Wessalowski R; Wilhelm M; Torsello S; Sager M; Güttler J; Jürgens H; Göbel U
    Med Pediatr Oncol; 1994; 22(6):393-7. PubMed ID: 8152401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Personal experience with isolated regional hyperthermic perfusion of cytostatic agents in tumors of the extremities].
    Bríza J; Lichtenberg J; Tersíp K; Tosovský J
    Rozhl Chir; 1989 Feb; 68(2):113-6. PubMed ID: 2718057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Isolation perfusion chemotherapy using cisplatin in malignant tumors of the extremities].
    Takeyama S; Tateishi A; Miki H; Yamanashi M; Hayashi I; Higaki S; Kozima T; Iizima T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1764-70. PubMed ID: 2543321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Technique and results of hyperthermic perfusion of the extremity in melanoma patients].
    Omlor G; Bahmer F; Meessen S; Zang D; Feifel G; Zaun H
    Langenbecks Arch Chir; 1993; 378(1):21-5. PubMed ID: 8437498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated limb infusion for melanoma: a less morbid alternative to hyperthermic isolated limb perfusion in the US.
    Santillan AA; Zager JS
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1033-7. PubMed ID: 20078252
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of hyperthermic perfusion in the treatment of tumors of the extremities.
    Di Filippo F; Carlini S; Cavaliere F; Giannarelli D; Cavallero L; Moscarelli F; Aloe L; Cavaliere R
    Adv Exp Med Biol; 1990; 267():223-34. PubMed ID: 2088040
    [No Abstract]   [Full Text] [Related]  

  • 19. Peripheral nerve damage following isolated extremity perfusion with cis-platinum.
    Busse O; Aigner K; Wilimzig H
    Recent Results Cancer Res; 1983; 86():264-7. PubMed ID: 6316430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin and platinum pharmacokinetics during hyperthermic isolated limb perfusion for human tumours of the extremities.
    Guchelaar HJ; Hoekstra HJ; de Vries EG; Uges DR; Oosterhuis JW; Schraffordt Koops H
    Br J Cancer; 1992 Jun; 65(6):898-902. PubMed ID: 1319729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.